4.7Google rating Pan-IndiaClients across India CS-LedCA · CS · Advocate network JanakpuriNew Delhi office TransparentPricing, no hidden fees

ComplyKart Services

Term Sheet – Read It Right Before You Sign

Terms that protect you before the lawyers arrive. Your term sheet, negotiated sharp.

  • ✓Term sheet drafted
  • ✓Key commercial terms captured
  • ✓Investor-ready document
CA/CS-guided review Your documents and structure are checked before anything is filed.
Written scope first Inclusions and payable charges are explained before work begins.
Support till it’s done One team owns your filing, from the first call to the final handover.
Price on request
This work is scoped case by case. You get a fixed written quote before any work starts — no charge for asking.

Get a free callback

+91

Your details stay private — we only call about this enquiry.

Experience behind every engagement

A quick snapshot of the work so far.

Pan-IndiaClients Across India
CS-LedCA · CS · Advocate Network
End-to-EndSetup, Tax & Compliance
JanakpuriNew Delhi Office

Fees

Fees and packages for Term Sheet

Every requirement is a little different, so we quote after a short discussion — the consultation itself is free.

Custom quote

Term Sheet

Talk to a ComplyKart expert — we’ll understand your requirement and share an exact written quote before you pay anything.

Talk to us for a quote

Term Sheet Package Inclusions

  • Term sheet drafting: valuation and instrument
  • Liquidation preference and participation
  • Board, protective provisions and vesting
  • Exclusivity and confidentiality
  • Investor-ready draft with explainer call
Get a free callback

After you pay

What happens after you pay

Five steps, no guesswork — you always know exactly what comes next. Tap a step to see what it involves.

You pay securely. Payment is confirmed instantly, and your receipt with the written fee breakup lands in your inbox.

Is a term sheet the right document for your situation?

You need a term sheet when:

  • An investor has agreed to invest and you need to record the commercial terms before lawyers draft the definitive agreements. This is the classic startup fundraise — seed, Series A, and beyond.
  • You are negotiating a private equity or strategic investment and need a common reference point for valuation, rights and protections before diligence begins.
  • You are selling a stake or the whole company and want headline terms agreed (price, structure, exclusivity) before the SPA drafting starts.
  • Multiple founders or existing investors need to align on what the incoming investor is getting — the term sheet forces that conversation early.

A term sheet alone is not enough when:

  • You need enforceable rights. The term sheet is a blueprint; the shareholders agreement and share subscription agreement are the building. Rights like liquidation preference and anti-dilution only become enforceable when drafted into the definitive agreements.
  • The deal involves only founders with no outside investor — you need a founders agreement, not a term sheet.
  • You are documenting an already-closed understanding purely for the record — that is a job for the definitive agreements, not another preliminary document.

Binding vs non-binding — the distinction that actually matters

Ask ten founders whether a term sheet is binding and nine will say no. They are mostly right and dangerously imprecise.

The standard position: the term sheet as a whole is non-binding — a statement of intent, a moral commitment, a basis for drafting. The commercial terms (valuation, preference, board seats) create no enforceable obligations until they appear in the definitive agreements. If the deal dies after the term sheet, neither party can sue the other for the investment not happening.

But four categories of clauses are carved out as expressly binding, and they bite:

Confidentiality. The deal's existence and terms stay private. Breach it — by shopping the terms to another investor to spark a bidding war, for instance — and you have breached a contract, not just etiquette.

Exclusivity (no-shop). The company agrees not to solicit or entertain competing offers for a defined period, typically 30 to 90 days. This is the clause founders most often underestimate. During exclusivity, taking a call from another fund about "just exploring" can be a breach. The exclusivity clause usually has a defined period, a defined scope (no solicitation vs no negotiation at all), and sometimes a carve-out for unsolicited approaches. Read the exact wording — "shall not solicit" and "shall not engage in discussions" are very different obligations.

Governing law and dispute resolution. Even the preliminary stage needs a governing law — usually Indian law — and a mechanism for disputes about the term sheet itself.

Expenses. Who pays the legal and diligence costs if the deal does not close. Common formulations: each party bears its own costs; or the company reimburses the investor's costs up to a cap if the company walks away. Uncapped expense reimbursement is a red flag — it lets the investor run up diligence bills on your account.

Beyond the express carve-outs, there is a subtler risk: conduct. If the parties behave as though terms are agreed — the investor starts attending board meetings, the company stops all other fundraising and publicly announces the round — a court could find binding intent regardless of what the document says. The label "non-binding" helps, but it is not magic. Act consistently with the document's status until the definitive agreements are signed.

Term sheet vs LOI vs MOU — choosing the right preliminary document

Founders use these three terms interchangeably. Lawyers should not, because they signal different transactions.

A term sheet itemizes investment terms: valuation, security class, preference, anti-dilution, governance rights, exit mechanics. It is the native document of venture capital and private equity — detailed, numbers-heavy, and designed to convert directly into a share subscription agreement and shareholders agreement. If money is being invested into a company for equity, the term sheet is the right preliminary document.

A letter of intent (LOI) is the M&A native. It records the intent to acquire — headline price, deal structure (share vs asset purchase), exclusivity, diligence scope, and target timeline — without itemizing investor-style rights and preferences. An LOI leads to a share purchase agreement or asset purchase agreement. It tends to be shorter and less mechanical than a term sheet because the definitive SPA will carry the full warranty and indemnity architecture.

A memorandum of understanding (MOU) is the broadest of the three: a framework for cooperation — joint ventures, strategic partnerships, government collaborations — often explicitly stating it creates no binding obligations at all. MOUs lead to definitive JV agreements, collaboration agreements, or nothing (many MOUs are ceremonial). An MOU is the wrong document for a priced equity investment; it lacks the mechanical specificity the definitive agreements need.

The practical test: if the document needs to specify a liquidation preference multiple, it is a term sheet. If it needs to specify a purchase price and closing conditions, it is an LOI. If it needs to specify areas of cooperation without commercial mechanics, it is an MOU.

What must be decided before signing

Valuation — and the ESOP pool question. Pre-money vs post-money is arithmetic, but the ESOP pool placement is negotiation. An investor who wants a 10% ESOP pool "pre-money" is effectively making the founders pay for the entire pool out of their own dilution; a post-money pool shares the cost. On a ₹40 crore pre-money valuation with a ₹10 crore investment and a 10% pool, the difference is several percentage points of founder ownership — real money at exit. Settle this in the term sheet; it cannot be fixed later without reopening the valuation.

The instrument. Compulsorily convertible preference shares (CCPS) are the Indian venture standard — they carry the preference rights, convert to equity on defined triggers, and fit cleanly into the FEMA framework for foreign investors. Compulsorily convertible debentures (CCDs) are the debt-flavoured alternative. Plain equity is rare in institutional rounds because it cannot carry a liquidation preference. The instrument choice has tax and FEMA consequences — decide it with counsel, not after the term sheet.

Control vs economics. Every term sheet trades these two currencies. A founder might accept a lower valuation for fewer veto rights, or a higher liquidation multiple for a smaller board presence. Before signing, be explicit with yourself about which currency matters more for this round — because the term sheet will spend both.

Founder commitment. Investors will ask about vesting of founder shares, lock-in periods, and non-compete undertakings. Founder vesting — typically 3 to 4 years with a one-year cliff — is standard in institutional rounds even for founders who have been working for years. It feels insulting; it is actually the investor protecting the company against a founder departure. Negotiate the acceleration triggers (single-trigger vs double-trigger on acquisition) rather than fighting vesting itself.

The clauses that actually matter

Valuation and investment amount — the headline numbers

Pre-money valuation, investment amount, and the resulting post-money valuation and shareholding percentages. Insist the term sheet shows the math — price per share, fully diluted share count, and each party's percentage — because valuation disputes after signing almost always trace to someone doing the dilution arithmetic differently. Confirm whether the valuation is pre- or post-ESOP pool, and whether any existing convertible instruments (notes, SAFEs) are included in the fully diluted count.

Liquidation preference — who gets paid first

In any sale, merger, or liquidation — and "deemed liquidation" events usually include most acquisitions — the preference determines payout order. The market standard is a 1x non-participating preference: the investor chooses the higher of (a) getting their full investment back, or (b) their pro-rata share of proceeds as if converted to equity. In a good exit, they convert and take the pro-rata share; in a bad exit, they take their money back first and founders get the remainder.

A participating preference — money back plus a pro-rata share of the remainder ("double dipping") — is founder-hostile and increasingly rare in competitive rounds. A preference multiple above 1x (2x, 3x) is a distress signal — it appears in down rounds and rescue financings, not healthy fundraises. Check whether the preference is capped, whether dividends accrue, and exactly which events trigger it — the "deemed liquidation" definition decides whether a merger payout follows the preference waterfall or the pro-rata split.

Anti-dilution — protection against the down round

If the company later issues shares at a lower price than the investor paid, anti-dilution adjusts the investor's effective price. Broad-based weighted average — the market standard — uses a formula weighing the old price, the new lower price, and the number of shares issued at each. The adjustment is moderate and proportionate; it protects without punishing. Narrow-based weighted average uses a smaller denominator and adjusts more aggressively. Full ratchet — resetting the investor's price to the lowest new price regardless of how few shares were issued — is the nuclear option: a small down-round issuance can massively dilute founders. Full ratchet has largely disappeared from mainstream Indian venture deals; if you see it in a term sheet, treat it as a major negotiation point, not boilerplate.

Dividends — usually cosmetic, occasionally not

Most Indian venture term sheets specify non-cumulative dividends on preference shares at a nominal rate, payable only if declared. They rarely matter economically — startups do not pay dividends — but the clause interacts with the liquidation preference (are accrued dividends added to the preference amount?) and with FEMA (for foreign investors, the return profile must fit the regulatory framework). Do not trade real concessions for dividend terms; do make sure the accrual mechanics are clear.

Board composition — who sits at the table

Typical formulation: founders appoint X directors, the investor appoints Y, sometimes with an independent director or observer. The investor director is often more important than the numbers suggest — protective provisions give that director (or the investor separately) veto rights regardless of board arithmetic. Also settle: observer rights vs full directorship, quorum requirements (can the board meet without the investor director?), and committee representation. A board seat for the investor is standard; a board majority for the investor at Series A is not.

Protective provisions (reserved matters) — the veto list

The list of decisions the company cannot take without investor consent: selling the company, raising new capital, changing the capital structure, amending the MOA/AOA, declaring dividends, taking on debt beyond thresholds, related-party transactions, changing the business materially, appointing or removing key management. This list is the investor's real control lever — broader than the board seat. Founders should push back on operational items (hiring, budgets below materiality thresholds) while accepting structural ones (sale, new issuance, charter amendments). Every item on this list is a future permission slip; imagine needing each one in a hurry and negotiate accordingly.

Drag-along and tag-along — the exit mechanics

Drag-along lets specified majority holders force all other shareholders to join a sale of the company — typically triggered when holders of a defined majority (often including the investor) approve an acquisition. Without it, a small holder can block a 100% sale a buyer insists on. Founders should negotiate the drag trigger threshold, a minimum price condition (the drag cannot force a sale below a floor), and identical terms for all dragged shareholders.

Tag-along is the mirror: when majority holders sell, the minority can join the sale on the same terms and price, pro-rata. It protects founders and early investors from being left behind when a larger holder exits. The pro-rata mechanics matter — can the tag-along holder sell their entire stake, or only the same proportion the seller is selling?

Right of first refusal and pro-rata rights — staying in the game

ROFR gives existing investors (and sometimes the company) the right to buy shares before they are sold to an outsider — it controls who enters the cap table. Pro-rata rights let existing investors participate in future rounds to maintain their ownership percentage — the single most valuable ongoing right for an early investor, and the one founders most often try to limit. The term sheet should specify whether pro-rata rights are broad (all future issuances) or limited, and whether they can be assigned.

Founder vesting, lock-in and ESOP — the people terms

Founder share vesting (3–4 years, one-year cliff is standard), lock-in periods restricting founder share sales, and the ESOP pool size and placement (pre- vs post-money, as discussed above). Also: non-compete and non-solicitation undertakings from founders — remember Section 27 of the Contract Act limits post-employment restraints, so these must be reasonably scoped and tied to the investment. Key-man insurance sometimes appears here too.

Information rights — the reporting burden

Monthly MIS, quarterly financials, annual audited accounts, annual budgets, inspection rights. The burden is real — a founder sending detailed monthly investor reports is spending hours that could go to the business. Negotiate the frequency and format realistically: quarterly financials plus annual audit is standard; monthly MIS with extensive granularity is negotiable. What matters is that the obligation is one you will actually fulfil — breached information covenants become ammunition in every future dispute.

Exit rights — IPO, buyback, and the put option

The term sheet sketches the exit paths: IPO (with demand and piggyback registration-style rights adapted for Indian listings), buyback by the company, and sometimes a put option (the investor can require the founders or company to buy them out after a period, typically 5+ years). Put options against the company need careful structuring under company law and FEMA — a company buying back its own shares must satisfy the buyback provisions of the Companies Act, and assured returns to foreign investors trip FEMA's boundaries. Treat any "assured exit" language as a drafting challenge, not a promise.

Exclusivity, confidentiality, conditions precedent, expenses

The binding carve-outs (detailed above): exclusivity period and scope, confidentiality obligations, CPs to definitive documentation (diligence, approvals, no material adverse change), and expense allocation. Also common: a governing-law clause and a "no binding obligation" statement with the carve-outs expressly listed. Check that the carve-out list in the "binding" paragraph actually matches the clauses drafted as binding in the body — mismatches here are a classic drafting slip.

How the term sheet becomes the definitive agreements

Signing the term sheet starts the second phase. Due diligence runs — legal, financial, sometimes technical and tax. The findings feed into the definitive agreements: issues become conditions precedent, specific indemnities, or price adjustments.

The definitive set for a fundraise is typically two documents, sometimes one. The share subscription agreement (SSA) records the fresh issue: number and class of shares, subscription price, closing mechanics, conditions precedent, and the company's and promoters' representations and warranties. The shareholders agreement (SHA) records the ongoing relationship: the term sheet's governance terms translated into full legal machinery — board composition, reserved matters, transfer restrictions, drag/tag, liquidation waterfall, anti-dilution formulae, information rights, exit provisions, and dispute resolution. In many Indian deals the two are combined into a single share subscription and shareholders agreement (SSHA).

The translation from term sheet to SHA is where deals are won and lost in the fine print. "Standard protective provisions" in the term sheet becomes a fifteen-item veto list in the SHA. "Customary drag-along" becomes three pages of trigger thresholds, price floors and procedural mechanics. This is why the term sheet review matters: every vague phrase becomes someone's drafting advantage. The founders' lawyer's job in this phase is to hold the SHA to the term sheet — no new rights smuggled in, no agreed protections quietly narrowed.

For acquisitions, the term sheet (or LOI) converts into the share purchase agreement — with its warranty, indemnity and escrow architecture — covered on our dedicated SPA page.

Common mistakes we see

Treating "non-binding" as "no consequences." The exclusivity clause is binding. Shopping the deal during the no-shop period — even "just taking a meeting" — is a breach with contractual consequences. Founders who believe the whole document is casual routinely trip on this one clause.

Signing without modelling the liquidation waterfall. A 1x participating preference vs 1x non-participating looks like a small difference in the term sheet. At a mediocre exit, it is the difference between founders receiving crores and receiving nothing. Model three exit scenarios (great, okay, bad) before signing — the preference clause decides the bad-exit outcome entirely.

Ignoring the ESOP pool placement. Pre-money vs post-money pool placement shifts several percentage points of ownership. It is the most expensive single line in many term sheets, and founders routinely sign without noticing it.

Accepting full-ratchet anti-dilution as boilerplate. It is not standard. Broad-based weighted average is the market standard. Full ratchet in a Series A term sheet is either a distress signal or a negotiation anchor — either way, push back.

Leaving the veto list for "later." "Standard protective provisions" becomes fifteen specific vetoes in the SHA. If the term sheet does not list them, the investor's lawyers will — and "standard" will mean their standard. Itemize the reserved matters in the term sheet or accept the consequences in the SHA.

No lawyer on the founder's side. The investor's lawyers drafted the term sheet. Reading it without your own counsel is like playing a match where the other side wrote the rules. The cost of a term sheet review is trivial next to the cost of a bad preference clause compounding over a decade.

Documents and information we need from you

If you have received a term sheet: the term sheet itself; your current cap table (fully diluted, including ESOP pool and convertibles); the existing shareholders agreement and AOA (to check how the new terms interact with existing rights — anti-dilution and preference stacking across rounds is where conflicts hide); last round's valuation and terms for comparison.

If you want one drafted: the commercial terms as you understand them (valuation, amount, instrument); cap table; existing investor rights summary; founder vesting expectations; any FEMA considerations (foreign investor → CCPS structuring, pricing guidelines for the subscription price).

For the definitive phase: incorporation documents, statutory registers, material contracts, litigation summary, IP assignments, employment and ESOP scheme documents — the diligence set that feeds the SSA warranties.

Our process — step by step

1. Term sheet triage

You send us the term sheet (or the commercial proposal). We read it the way the SHA will read it — translating each shorthand phrase into its definitive-agreement consequences — and produce a clause-by-clause risk note: what is market, what is aggressive, what needs modelling, what must change.

2. Scenario modelling

For the economic clauses — valuation with ESOP pool placement, liquidation waterfall, anti-dilution mechanics — we model the outcomes across exit scenarios so you sign with numbers, not impressions.

3. Negotiation support

We mark up the term sheet, join the negotiation calls if needed, and push the aggressive terms back to market. The goal is a balanced term sheet both sides can live with for the life of the investment — not a "win" that poisons the relationship.

4. Drafting (investor-side or company-side)

If you are issuing the term sheet, we draft it cleanly: commercial terms precise, binding carve-outs explicit, no ambiguous shorthand that becomes a fight in the SHA phase.

5. Definitive agreements

We draft or review the SSA and SHA (or SSHA) holding every clause to the term sheet — no new rights smuggled in, no agreed protections narrowed. Warranties, CPs, closing mechanics and filings through to allotment.

6. Closing and filings

Board and shareholder approvals, allotment, filing of PAS-3 (return of allotment) with the ROC, updating the register of members, FEMA reporting for foreign investment (FC-GPR), and stamp duty on the share issuance.

How long does it take?

Term sheet review: 2 to 3 working days for a full clause-by-clause risk note. Term sheet drafting: 3 to 5 working days. Negotiation: 1 to 3 weeks depending on the parties. The definitive phase — diligence plus SSA/SHA drafting and negotiation — typically runs 4 to 8 weeks after the term sheet is signed. A clean seed round can go from term sheet to money in the bank in 6 weeks; a complex Series A with diligence findings runs 10 to 14 weeks.

How ComplyKart helps

Term sheet review. A clause-by-clause risk note in plain language: what each term means in SHA reality, what is market vs aggressive, and what to renegotiate — with exit-scenario modelling for the economic clauses.

Term sheet drafting. For investors and companies issuing term sheets: clean, precise drafts with explicit binding carve-outs and no ambiguous shorthand.

Negotiation. We negotiate the terms directly or arm you with the markup and the arguments — your choice.

Definitive agreements. SSA, SHA, or combined SSHA drafting and review, held strictly to the term sheet — plus closing mechanics, PAS-3 filings, register updates, and FEMA reporting (FC-GPR) for foreign investors.

What we do not do: we do not advise on valuation itself (we model agreed numbers; the commercial valuation is between you and the investor, with a registered valuer where regulations require); we do not shop your deal to investors; and we cannot make a counterparty accept terms — negotiation needs both sides willing.

What happens after signing

In the first 30 days: due diligence begins; lawyers are engaged on both sides; the CPs to definitive documentation (diligence satisfaction, approvals) start getting ticked off. The exclusivity clock is running — honour it.

At definitive signing: the SSA and SHA are executed; conditions precedent to closing are satisfied or waived; the subscription money is wired; shares are allotted.

After closing: PAS-3 filed with the ROC within the statutory timeline; register of members updated; share certificates issued; FC-GPR filed for foreign investment; the SHA's ongoing machinery — board processes, reserved-matter consents, information rights — becomes the company's operating reality. The term sheet itself is filed away; its job is done.

Sources

This page is built on the Indian Contract Act, 1872 (binding vs non-binding intent, Section 27 on restraints of trade), the Companies Act, 2013 (share issuance, buyback, PAS-3 filings), the Foreign Exchange Management (Non-debt Instruments) Rules, 2019 (pricing and reporting for foreign investment), SEBI's framework for public offerings, and standard Indian venture-capital and private-equity deal practice as reflected in practitioner commentary. Deal practice evolves — we verify current market positions at the time of engagement.

FAQ

Frequently asked questions

21 answers from our consultants.

You pay for our expert's time — document checking, filing, follow-ups — not the government. The government fee goes to the government; our fee is for the work we do so you don't have to figure it out yourself.

Tell us your situation in plain words — what you're trying to do, not which form you think you need. Half our job is stopping clients from buying the wrong service. The first consultation is free and honest.

Yes. We quote professional fee + government charges + taxes separately, in writing, before you pay. The number doesn't change midway. If the government fee changes, we show you the notification.

Every engagement gets a tracker — you see what's filed, what's pending and what's next. No chasing on WhatsApp for status updates.

A mechanism that adjusts the investor's effective share price if the company later issues shares cheaper (a down round). Broad-based weighted average — the market standard — adjusts by formula considering shares issued; it is moderate and founder-friendly. Full ratchet resets to the lowest new price and severely dilutes founders — push back hard if you see it.

Drag-along lets majority holders force minority holders to join a company sale, so a buyer can acquire 100%. Tag-along lets minority holders join a majority-initiated sale on the same terms and price. Negotiate the drag trigger threshold and a minimum price floor; confirm tag-along is pro-rata on identical terms.

A term sheet itemizes investment terms (valuation, preference, rights) and leads to an SSA and SHA — it is the venture capital native. An LOI records acquisition intent (price, structure, exclusivity) and leads to an SPA — the M&A native. An MOU frames broad cooperation (JVs, partnerships) and is often explicitly non-binding. Use the document that matches your transaction.

Pre-money is the company's value before the investment; post-money is pre-money plus the investment. A ₹40 crore pre-money valuation with ₹10 crore invested means ₹50 crore post-money and the investor holds 20%. Always confirm the math in the term sheet — price per share, fully diluted count, percentages — because valuation disputes trace to arithmetic, not intent.

This is pure negotiation with real money attached. A pre-money pool comes entirely out of the founders' dilution; a post-money pool shares the cost with the investor. On typical numbers the difference is several percentage points of founder ownership. Settle it in the term sheet — it cannot be fixed later without reopening valuation.

Veto rights giving the investor consent power over specified company decisions — sale of the company, new share issues, charter amendments, debt beyond thresholds, related-party transactions, material business changes. This list is the investor's real control lever. Push back on operational items; accept structural ones; and imagine needing each consent in a hurry before agreeing.

A binding commitment not to solicit or entertain competing investment offers for a defined period (typically 30–90 days). "Shall not solicit" vs "shall not engage in discussions" are very different obligations — read the exact wording. Breaching it, even by "just taking a meeting," is a breach of contract.

Yes. The investor's lawyers drafted it. Every shorthand phrase ("standard protective provisions," "customary drag-along") unpacks into pages of SHA machinery that will govern your company for a decade. A review costs little; a bad preference clause compounds for years. This is the highest-ROI legal spend in a fundraise.

Founder shares vesting over 3–4 years with a one-year cliff — if a founder leaves early, unvested shares are forfeited or repurchased. It protects the company (and the investor) against founder departure. Negotiate acceleration triggers (what happens to vesting on acquisition — single vs double trigger) rather than fighting vesting itself.

Compulsorily convertible preference shares (CCPS) — the Indian venture standard — carry preference rights (liquidation preference, anti-dilution, dividends) and convert to equity on defined triggers. Plain equity cannot carry a liquidation preference, which is why institutions rarely take it. CCPS also fits the FEMA framework for foreign investors cleanly.

Yes. The valuation is non-binding commercial intent. If due diligence uncovers issues — revenue misstatements, undisclosed liabilities, IP gaps — the investor can reprice or walk away. Material findings become price adjustments, specific indemnities, or additional conditions precedent in the definitive agreements.

The right of existing investors to participate in future funding rounds to maintain their ownership percentage — the most valuable ongoing right for an early investor. The term sheet should specify scope (all future issuances vs limited) and assignability. Founders often try to narrow them; investors fight to keep them broad.

The definition — usually in the liquidation preference clause — of which events trigger the preference waterfall. It typically includes mergers, acquisitions, and sales of substantially all assets, not just formal winding-up. The exact definition decides whether an acquisition payout follows the preference order or a pro-rata split. Read it carefully; it is frequently negotiated.

Typically 30 to 90 days. It should be long enough for diligence and definitive drafting but not so long that the company is hostage if the investor goes slow. If the investor has not progressed meaningfully, the company should be able to terminate exclusivity — check whether the clause allows that or locks you in for the full period unconditionally.

The term sheet's expense clause governs legal and diligence costs if the deal dies. Common: each side bears its own costs, or the company reimburses the investor's costs up to a cap if the company walks away. Uncapped reimbursement is a red flag — it lets the investor run up bills on your account. Cap it, and define what counts.

Both relate to IPO exits. Demand rights let the investor require the company to facilitate a public offering; piggyback rights let the investor join an offering the company is already doing. In the Indian context these are adapted to SEBI's IPO framework rather than imported wholesale from US practice — ensure the SHA drafting reflects Indian listing mechanics.

The commercial terms are non-binding, so legally yes — but practically, reopening settled terms damages trust and momentum. The time to negotiate is before signing. After signing, changes should be limited to issues diligence genuinely uncovers. This is why the pre-signing review matters so much: sign it right the first time.

What clients say about working with us

Real stories from businesses we've worked with.

Trademark Registration
Our Trademark was applied in all the classes with a short span of time by Complykart Trademark Experts and I can say the level of expertise and commitment they carry is remarkable. It's an A+ from my side. We are now sticking to ComplyKart only.
Rajat KhanejaKnovalt
Company Registration
I found the professionalism of the staff at complykart.com, a pleasure to work with. As a foreigner to India, they took the time to explain the documentation and assisted in every question I raised. I was pleased that complykart.com made it easy for my Business.
Ravi Sharma360Mart Trading
Merger & Acquisition
Trust, Commitment, Dedication and responsiveness are the best things with ComplyKart. Thanks for handling our Merger assignment with so much care. After my business disputes, complykart handles all things with own sense of understanding.
Rana RajeshAIL

Learning center

Guides on Term Sheet

Deeper reading from our articles — the same rules, explained in plain words.

Pankaj Jain

Reviewed by

Pankaj Jain

Senior Consultant · ESOP, Trademark & General Advisory · 14+ years experience

Pankaj Jain is a senior consultant covering ESOP structuring, trademark and IP protection, accounting advisory and legal documentation. With the broadest practice at the firm, he handles the matters that don’t fit neatly in one box.

Last reviewed: 16 November 2026

Get a free consultation

Talk to a ComplyKart professional about Term Sheet. The first consultation is free.

Talk to an expert — free
Free expert callback For Term Sheet — a CA, CS or advocate will call you back